14 insiders reported 145 Form 4 transactions for Alkermes plc. (ALKS) over the past 18 months (most recent 2026-09-03). Recent activity: Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) Sell 2,034 shares, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) Buy 5,000 shares, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) Sell 9,000 shares, Nichols Christian Todd (SVP, Chief Commercial Officer) Sell 6,912 shares, Nichols Christian Todd (SVP, Chief Commercial Officer) Sell 664 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $97,652 |
| 2026-09-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Buy | 5,000 | $122,950 |
| 2026-09-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $422,874 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 6,912 | $339,967 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell | 664 | $32,969 |
| 2026-08-03 | snyderman nancy lynn MD | Director | Buy | 27,948 | $1.3M |
| 2026-08-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $98,812 |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Buy | 104 | $2,011 |
| 2026-08-03 | snyderman nancy lynn MD | Director | Buy | 16,524 | $772,001 |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Buy | 4,896 | $120,393 |
| 2026-08-03 | snyderman nancy lynn MD | Director | Sell | 44,472 | $2.2M |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $437,220 |
| 2026-07-06 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $109,897 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Buy | 5,000 | $96,700 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 8,300 | $427,129 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 700 | $36,492 |
| 2026-06-12 | Wright Christopher I | Director | Sell | 2,000 | $90,200 |
| 2026-06-04 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell | 2,034 | $87,564 |
| 2026-06-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Buy | 5,000 | $96,700 |
| 2026-06-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $375,030 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Buy | 3,392 | $67,942 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Buy | 12,825 | $248,036 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell | 16,217 | $686,952 |
| 2026-05-22 | Lurker Nancy | Director | Buy | 6,142 | $0 |
| 2026-05-22 | Lurker Nancy | Director | Sell | 1,475 | $54,501 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03